share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：擬議出售證券
美股SEC公告 ·  10/03 04:36

牛牛AI助理已提取核心訊息

Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
arcutis biotherapeutics公司官員Larry Todd Edwards計劃於2024年10月2日賣出3725股普通股。這些股票總價值37295美元，是通過2024年10月1日從arcutis biotherapeutics直接獲得的受限制的股票授予。根據提供的交易歷史記錄，這筆交易是在過去三個月中Edwards未出售證券的情況下進行的。
arcutis biotherapeutics公司官員Larry Todd Edwards計劃於2024年10月2日賣出3725股普通股。這些股票總價值37295美元，是通過2024年10月1日從arcutis biotherapeutics直接獲得的受限制的股票授予。根據提供的交易歷史記錄，這筆交易是在過去三個月中Edwards未出售證券的情況下進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間